Fundraising Fox

Proclara Biosciences

Cambridge, US · Delaware corporation

Biotech

Founders & leadership

JS
Jonathan SolomonFounder
HH
Hampus HillerstromExecutive
RF
Richard Fischer, Ph.D.Executive
FH
Franz Hefti, Ph.D.Executive

Board

HS
Hans SchoepflinBoard director
NL
Nick LeschlyBoard director
PS
Peter SmedvigBoard director
JD
John DeeBoard director
DL
Daniel LynchBoard director
VC
Valerie CalendaBoard director
PG
Paul Goldenheim, MDBoard director
VS
Vicki SatoBoard director

Reported raises · per SEC filings

Form D private placements

$64.7M disclosed across 4 rounds · 2012–2018

▶$6.9MraisedNov 2018 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Valerie Calenda, Ph.D.Director
  • Franz Hefti, Ph.D.Director
  • Richard A. Fisher, Ph.D.Executive Officer, Director
  • Kenneth BuckfireDirector
  • David Michelson, M.D.Director
Offering amount
$10M
Amount sold
$6.9M
First sale
Nov 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$43MraisedNov 2016 · 50 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Hans SchoepflinDirector
  • Nick LeschlyDirector
  • Hampus HillerstromExecutive Officer
  • Richard Fischer, Ph.D.Executive Officer
  • Paul Goldenheim, MDDirector
  • Peter SmedvigDirector
  • John DeeDirector
  • Daniel LynchDirector
  • Franz Hefti, Ph.D.Executive Officer, Director
Offering amount
$47M
Amount sold
$43M
First sale
Feb 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5.7MraisedApr 2014 · 54 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Francois ValenconyDirector
  • Hampus HillerstromExecutive Officer
  • Jonathan SolomonExecutive Officer, Director
  • Peter SmedvigDirector
  • Kenneth BuckfireDirector
  • Paul GoldenheimDirector
  • John DeeDirector
  • Nico DosenbachDirector
  • Vicki SatoDirector
Offering amount
$17.1M
Amount sold
$5.7M
Minimum investment
$820
First sale
Mar 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$9MraisedMar 2012 · 31 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Hampus HillerstromExecutive Officer, Director
  • Jonathan SolomonExecutive Officer, Director
  • Vicki SatoDirector
  • Valerie CalendaDirector
  • Paul GoldenheimDirector
Offering amount
$9M
Amount sold
$9M
First sale
Mar 2012
Incorporated
Corporation, Delaware
Federal exemptions
06
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Proclara Wins $250K BPA Grant to Develop AD Drug Targeting Protein Misfoldinggenengnews.com · Mar 2017Proclara Biosciences raises $43 mln in equity financing | Reutersreuters.com · Nov 2016Proclara Biosciences Announces $47 Million in New Investment to Support the Development of Product Candidates in Alzheimer’s, Parkinson’s and Other Diseases | Business Wirebusinesswire.com · Sep 2016Proclara gets $47m and a new identity -globalventuring.com · Sep 2016NeuroPhage Transforms Into Proclara, Bags $47 Million and and Launches Phase Ib Alzheimer’s Trial - BioSpacebiospace.com · Sep 2016

Frequently asked questions

Who founded Proclara Biosciences?
Proclara Biosciences was founded by Jonathan Solomon.
How much funding has Proclara Biosciences raised?
Proclara Biosciences has disclosed $64.7M raised across 4 rounds.
Where is Proclara Biosciences headquartered?
Proclara Biosciences is headquartered in Cambridge, US.